Get notified when ZNTL files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsZentalis Pharmaceuticals reports Q1 2026 financial results and business updates
Filed May 12, 2026 · Period ending May 12, 2026 · ~1 min read
Key Changes
-
high
Company announced financial results for the quarter ended March 31, 2026, along with business updates. Specific metrics are contained in the press release furnished as an exhibit.
Item 2.02 verify on EDGAR → -
low
Zentalis furnished a corporate presentation for use at investor conferences and analyst meetings beginning May 12, 2026, ensuring public access to materials shared in private meetings.
Item 7.01 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade ZNTL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify